These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service. Kamin J; Manwani S; Hughes D Psychiatr Serv; 2000 Mar; 51(3):287-9. PubMed ID: 10686232 [No Abstract] [Full Text] [Related]
3. Scopolamine for Management of Extrapyramidal Side Effects as a Result of Antipsychotic Medication Use: A Case Report and Brief Review of the Literature. Lampignano D; Sharma TR Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27733951 [No Abstract] [Full Text] [Related]
4. [Use of anticholinergic antiparkinson agents against adverse drug reactions in a psychiatric department. A quality assurance project]. Mikkelsen VR Ugeskr Laeger; 1998 Jul; 160(29):4323-5. PubMed ID: 9679438 [No Abstract] [Full Text] [Related]
5. Half the dose of antipsychotic in case of extrapyramidal symptoms. Tort AB; Souza DO; Lara DR Schizophr Res; 2005 Oct; 78(2-3):347-9. PubMed ID: 16005192 [No Abstract] [Full Text] [Related]
11. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. Procyshyn RM; Honer WG; Wu TK; Ko RW; McIsaac SA; Young AH; Johnson JL; Barr AM J Clin Psychiatry; 2010 May; 71(5):566-73. PubMed ID: 20361903 [TBL] [Abstract][Full Text] [Related]
12. Anticholinergics to treat antipsychotic-induced extrapyramidal symptoms: Time to avoid this practice. Koola MM Asian J Psychiatr; 2018 Jan; 31():100-101. PubMed ID: 29454175 [No Abstract] [Full Text] [Related]
13. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes. Dose M Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drug side effects: their relationship to dose. Kane JM J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic polypharmacy does not increase the risk for side effects. Ganesan S; Taylor R; Rabheru K; Forbes I; Dumontet J; Procyshyn RM Schizophr Res; 2008 Jan; 98(1-3):323-4. PubMed ID: 17950576 [No Abstract] [Full Text] [Related]
16. Abuse potential of anticholinergics. Dose M; Tempel HD Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():43-6. PubMed ID: 11072764 [TBL] [Abstract][Full Text] [Related]
17. Is relapse a justification for the use of high-dose antipsychotics? Cohen S; Chiles JA J Clin Psychiatry; 1990 Nov; 51(11):486-7. PubMed ID: 1977741 [No Abstract] [Full Text] [Related]
18. [The effect of dexbenzetimide (Tremblex - Gedeon Richter) on postneuroleptic extrapyramidal syndromes (author's transl)]. Firko M; Morasiewicz J; PuchaĆa G Psychiatr Pol; 1981; 15(2):139-44. PubMed ID: 6118905 [No Abstract] [Full Text] [Related]
19. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial. Thompson A; Sullivan SA; Barley M; Strange SO; Moore L; Rogers P; Sipos A; Harrison G Psychol Med; 2008 May; 38(5):705-15. PubMed ID: 17825122 [TBL] [Abstract][Full Text] [Related]
20. Neuroleptic dosage for Asians. Lin KM; Finder E Am J Psychiatry; 1983 Apr; 140(4):490-1. PubMed ID: 6132560 [No Abstract] [Full Text] [Related] [Next] [New Search]